OTC Pharmaceuticals - Israel | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$918.30m in 2024. The market is expected to grow annually by 4.72% (CAGR 2024-2029).
The market's largest segment is the segment Vitamins & Minerals with a market volume of US$375.60m in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$98.61 are generated in 2024.
In the OTC Pharmaceuticals market, 20.6% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Israel has been experiencing steady growth in recent years, driven by various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the OTC Pharmaceuticals market in Israel have been shifting towards self-care and convenience.

With increasing awareness about health and wellness, consumers are becoming more proactive in managing their own health. They are seeking over-the-counter medications that can help them treat minor ailments and symptoms without the need for a prescription. This preference for self-care is driving the demand for OTC Pharmaceuticals in Israel.

Trends in the market are also contributing to the growth of the OTC Pharmaceuticals market in Israel. One notable trend is the increasing availability and popularity of natural and herbal remedies. Consumers are becoming more interested in alternative and holistic approaches to healthcare, and are seeking OTC medications that are derived from natural ingredients.

This trend is driving the development and introduction of new OTC products in the market. Local special circumstances in Israel are also influencing the growth of the OTC Pharmaceuticals market. The country has a well-developed healthcare system and a high level of healthcare expenditure.

This enables consumers to have easy access to a wide range of OTC medications and healthcare products. Additionally, the government has implemented policies to promote the use of OTC medications as a means to reduce the burden on the healthcare system. These factors create a favorable environment for the growth of the OTC Pharmaceuticals market in Israel.

Underlying macroeconomic factors are also playing a role in the development of the OTC Pharmaceuticals market in Israel. The country has a strong economy and a high standard of living, which allows consumers to afford OTC medications. Additionally, the aging population in Israel is increasing the demand for OTC medications, as older individuals are more likely to experience health issues that can be managed with over-the-counter treatments.

In conclusion, the OTC Pharmaceuticals market in Israel is experiencing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. As consumers become more proactive in managing their own health, the demand for OTC medications is increasing. The availability of natural and herbal remedies, along with the country's well-developed healthcare system, further contribute to the growth of the market.

With a strong economy and an aging population, Israel presents a favorable environment for the development of the OTC Pharmaceuticals market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.